JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB11672

Anti-Sumo 1 antibody

4

(4 Reviews)

|

(36 Publications)

Rabbit Polyclonal Sumo 1 antibody. Suitable for IHC-P, IP and reacts with Human samples. Cited in 36 publications. Immunogen corresponding to Recombinant Full Length Protein corresponding to Human SUMO1.

View Alternative Names

SMT3C, SMT3H3, UBL1, OK/SW-cl.43, SUMO1, Small ubiquitin-related modifier 1, SUMO-1, GAP-modifying protein 1, SMT3 homolog 3, Sentrin, Ubiquitin-homology domain protein PIC1, Ubiquitin-like protein SMT3C, Ubiquitin-like protein UBL1, GMP1, Smt3C

2 Images
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Sumo 1 antibody (AB11672)
  • IHC-P

Unknown

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-Sumo 1 antibody (AB11672)

ab11672 staining human normal placenta. Staining is localized to the nucleus and nuclear membrane.
Left panel : with primary whole serum antibody at 1/400. Right panel : isotype control.
Sections were stained using an automated system DAKO Autostainer Plus , at room temperature. Sections were rehydrated and antigen retrieved with the Dako 3-in-1 AR buffer EDTA pH 9.0 in a DAKO PT Link. Slides were peroxidase blocked in 3% H2O2 in methanol for 10 minutes. They were then blocked with Dako Protein block for 10 minutes (containing casein 0.25% in PBS), then incubated with primary antibody for 20 minutes, and detected with Dako Envision Flex amplification kit for 30 minutes. Colorimetric detection was completed with diaminobenzidine for 5 minutes. Slides were counterstained with Haematoxylin and coverslipped under DePeX. Please note that for manual staining we recommend to optimize the primary antibody concentration and incubation time (overnight incubation), and amplification may be

Immunoprecipitation - Anti-Sumo 1 antibody (AB11672)
  • IP

Unknown

Immunoprecipitation - Anti-Sumo 1 antibody (AB11672)

293T cells were transfected with a vector that has Sumo1 fused to GFP and a Flag tag. Cell lysates were used in IP with ab11672 (and a GFP antibody as a control). The resulting western blot was performed with a Flag antibody. As a control, cells were transfected with a a vector with Sumo2 fused to GFP and a Flag tag. ab11672 does not IP anything from this lysate.

Lane 1 : Sumo1 fusion lysate - IP'd with GFP antibody

Lane 2 : Sumo1 fusion lysate - no IP

Lane 3 : Sumo1 fusion lysate - IP'd with ab11672

Lane 4 : Sumo2 fusion lysate - IP'd with ab11672

All lanes:

Immunoprecipitation - Anti-Sumo 1 antibody (ab11672)

Predicted band size: 11 kDa

false

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Human

Applications

IHC-P, IP

applications

Immunogen

Recombinant Full Length Protein corresponding to Human SUMO1.

P63165

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/400", "IHCP-species-notes": "<p></p>", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "", "IP-species-notes": "<p></p>" } } }

Properties and storage information

Form
Liquid
Purity
Whole antiserum
Storage buffer
Preservative: 0.05% Sodium azide
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

SUMO 1 also known as small ubiquitin-like modifier 1 is part of the protein family involved in post-translational modification. The protein mechanically adds a SUMO group to target proteins through sumoylation a process similar to ubiquitination. SUMO 1 typically has a molecular mass of around 11 kDa. It expresses in various tissues and cells including the nucleus and cytoplasm of eukaryotic cells. In addition it is important in processes like nuclear transport transcriptional regulation and protein stabilization.
Biological function summary

SUMO 1 contributes significantly to maintaining cellular homeostasis. It is an integral part of a SUMOylation complex that modifies other proteins to alter their function localization or interactions. Through its modification actions SUMO 1 affects processes such as DNA repair and the cell cycle. By interacting with components of the nuclear pore complex and transcription factors SUMO 1 modulates essential biological activities at multiple levels within the cell.

Pathways

This protein plays a significant role in the PI3K/Akt pathway and Wnt signaling. SUMO 1 associates with proteins like RanGAP1 and various transcription factors highlighting the complexity of its regulatory actions. These associations are important for the regulation of cell survival proliferation and differentiation. SUMOylation by SUMO 1 has been linked to an interference with phosphorylation showing its potential influence on cell signaling pathways.

The dysregulation of SUMO 1 is seen in cancer and neurodegenerative diseases. For instance altered SUMOylation patterns contribute to the progression of certain cancers. Furthermore SUMO 1 interacts with proteins like p53 and these interactions can affect tumor suppression and cell cycle regulation. In neurodegenerative disorders disturbed SUMOylation is associated with protein aggregation and neuronal damage implicating SUMO 1 in diseases like Alzheimer's.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Ubiquitin-like protein that can be covalently attached to proteins as a monomer or a lysine-linked polymer. Covalent attachment via an isopeptide bond to its substrates requires prior activation by the E1 complex SAE1-SAE2 and linkage to the E2 enzyme UBE2I, and can be promoted by E3 ligases such as PIAS1-4, RANBP2 or CBX4. This post-translational modification on lysine residues of proteins plays a crucial role in a number of cellular processes such as nuclear transport, DNA replication and repair, mitosis and signal transduction. Involved for instance in targeting RANGAP1 to the nuclear pore complex protein RANBP2. Covalently attached to the voltage-gated potassium channel KCNB1; this modulates the gating characteristics of KCNB1 (PubMed : 19223394). Polymeric SUMO1 chains are also susceptible to polyubiquitination which functions as a signal for proteasomal degradation of modified proteins. May also regulate a network of genes involved in palate development. Covalently attached to ZFHX3 (PubMed : 24651376).
See full target information SUMO1

Publications (36)

Recent publications for all applications. Explore the full list and refine your search

Science advances 9:eadl2108 PubMed38055822

2023

RAD54L2 counters TOP2-DNA adducts to promote genome stability.

Applications

Unspecified application

Species

Unspecified reactive species

Giuseppina D'Alessandro,David A Morales-Juarez,Sean L Richards,Karin C Nitiss,Almudena Serrano-Benitez,Juanjuan Wang,John C Thomas,Vipul Gupta,Andrea Voigt,Rimma Belotserkovskaya,Chen Gang Goh,Anne Ramsay Bowden,Yaron Galanty,Petra Beli,John L Nitiss,Guido Zagnoli-Vieira,Stephen P Jackson

Journal of pharmaceutical analysis 13:170-186 PubMed36908856

2023

SUMO1 regulates post-infarct cardiac repair based on cellular heterogeneity.

Applications

Unspecified application

Species

Unspecified reactive species

Zhihao Liu,Xiaozhi Liu,Li Liu,Ying Wang,Jie Zheng,Lan Li,Sheng Li,Han Zhang,Jingyu Ni,Chuanrui Ma,Xiumei Gao,Xiyun Bian,Guanwei Fan

Cell death & disease 14:147 PubMed36810326

2023

Glioblastoma upregulates SUMOylation of hnRNP A2/B1 to eliminate the tumor suppressor miR-204-3p, accelerating angiogenesis under hypoxia.

Applications

Unspecified application

Species

Unspecified reactive species

Qindong Guo,Yang Fan,Qingtong Wang,Boyan Li,Wei Qiu,Yanhua Qi,Ziwen Pan,Shouji Zhang,Shulin Zhao,Kehui Yang,Hao Xu,Ming Li,Zijie Gao,Jianye Xu,Huizhi Wang,Shaobo Wang,Qilin Tang,Jiawei Qiu,Xing Guo,Lin Deng,Ping Zhang,Rongrong Zhao,Hao Xue,Chengwei Wang,Gang Li

Military Medical Research 9:58 PubMed36229865

2022

Cardiac-targeted PIASy gene silencing mediates deSUMOylation of caveolin-3 and prevents ischemia/reperfusion-induced Na1.5 downregulation and ventricular arrhythmias.

Applications

Unspecified application

Species

Unspecified reactive species

Chen-Chen Hu,Xin Wei,Jin-Min Liu,Lin-Lin Han,Cheng-Kun Xia,Jing Wu,Tao You,A-Fang Zhu,Shang-Long Yao,Shi-Ying Yuan,Hao-Dong Xu,Zheng-Yuan Xia,Ting-Ting Wang,Wei-Ke Mao

Oxidative medicine and cellular longevity 2022:8002566 PubMed35707278

2022

Ginkgolic acid improves bleomycin-induced pulmonary fibrosis by inhibiting SMAD4 SUMOylation.

Applications

Unspecified application

Species

Unspecified reactive species

Lan Yu,Xiyun Bian,Chunyan Zhang,Zhouying Wu,Na Huang,Jie Yang,Wen Jin,Zongqi Feng,Dongfang Li,Xue Huo,Ting Wu,Zhongmin Jiang,Xiaozhi Liu,Dejun Sun

Cell reports 37:110080 PubMed34879279

2021

The protease SPRTN and SUMOylation coordinate DNA-protein crosslink repair to prevent genome instability.

Applications

WB, IF

Species

Human, Human

Annamaria Ruggiano,Bruno Vaz,Susan Kilgas,Marta Popović,Gonzalo Rodriguez-Berriguete,Abhay N Singh,Geoff S Higgins,Anne E Kiltie,Kristijan Ramadan

Pharmacological research 172:105843 PubMed34428586

2021

Rg3 promotes the SUMOylation of SERCA2a and corrects cardiac dysfunction in heart failure.

Applications

WB

Species

Mouse

Zhihao Liu,Xiyun Bian,Wenbo Gao,Jing Su,Chuanrui Ma,Xiaolin Xiao,Tian Yu,Han Zhang,Xiaozhi Liu,Guanwei Fan

Biomedical and environmental sciences : BES 34:124-129 PubMed33685571

2021

Astragaloside IV Improves Angiogenesis and Promotes Wound Healing in Diabetic Rats the Activation of the SUMOylation Pathway.

Applications

ICC, WB

Species

Human, Human

Bao Shen Wang,Xiao Fang Ma,Chun Yan Zhang,Yan Xia Li,Xiao Zhi Liu,Chang Qing Hu

Molecular medicine reports 23: PubMed33537820

2021

Astragaloside IV improves angiogenesis under hypoxic conditions by enhancing hypoxia‑inducible factor‑1α SUMOylation.

Applications

Unspecified application

Species

Unspecified reactive species

Baoshen Wang,Chunyan Zhang,Dongmei Chu,Xiaofang Ma,Tian Yu,Xiaozhi Liu,Changqing Hu

JCI insight 5: PubMed32938830

2020

Increased SUMO-activating enzyme SAE1/UBA2 promotes glycolysis and pathogenic behavior of rheumatoid fibroblast-like synoviocytes.

Applications

WB

Species

Human

Cuicui Wang,Youjun Xiao,Minxi Lao,Jingnan Wang,Siqi Xu,Ruiru Li,Xuanxian Xu,Yu Kuang,Maohua Shi,Yaoyao Zou,Qingwen Wang,Liuqin Liang,Song Guo Zheng,Hanshi Xu
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com